Pursuing Innovation In A Changing China
This article was originally published in PharmAsia News
Pharmaceutical companies in China have no doubt felt the chill over the past two years from authorities’ eagerness to reshape the industry with stricter regulations and compliance requirements. But does China have the framework in place to encourage innovation?
You may also be interested in...
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.
Vydaqel saw its uptake take off in the US last year. UK’s NICE to pass judgement on cost effectiveness by June.
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.